Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method, oligonucleotide and kit for detecting high-risk HPV (human papilloma viruses)

An oligonucleotide and kit technology, applied in the field of detection of high-risk HPV, oligonucleotides and kits, can solve the problems of inability to type, increase the amount of samples and detection reagents, and increase the cost of detection, etc. The effect of ensuring the detection accuracy, reducing the background fluorescence value, and reducing the detection cost

Active Publication Date: 2016-05-25
ACON BIOTECH (HANGZHOU) CO LTD
View PDF4 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, because SYBRGreenI is an unsaturated dye, its specificity is not as good as that of the double-probe hybridization method and the Taqman probe method, and its specificity must be judged by observing the melting curve; and the cost of the double-probe hybridization method is relatively expensive.
[0009] At present, in the domestic market, many manufacturers have developed products based on the fluorescent PCR method to detect high-risk HPV, and most of them detect 13, 14 or 15 high-risk HPV at the same time. Only a few manufacturers use the fluorescent PCR method to develop simultaneous detection Products of 18 common high-risk HPV types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 26, 53, 66, 73 and 82), however, in Some of these products design a pair of type-specific primers and a type-specific probe for each high-risk HPV type, which will drastically increase the cost of detection, and the existence of so many probes will also significantly increase the background fluorescence signal; some It is still necessary to perform multi-tube detection, which will significantly increase the amount of samples and detection reagents, increase the cost of detection, and cannot type HPV16 and HPV18; what's more, primers and / or probes designed for different high-risk HPV The needles are limited to the same gene region, and the base sequence difference is too small, which will lead to crossover amplification reactions, false positives, and the specific types cannot be accurately distinguished

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method, oligonucleotide and kit for detecting high-risk HPV (human papilloma viruses)
  • Method, oligonucleotide and kit for detecting high-risk HPV (human papilloma viruses)
  • Method, oligonucleotide and kit for detecting high-risk HPV (human papilloma viruses)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1: sample DNA extraction

[0047] For the sake of illustration, this embodiment takes a cervical cotton swab sample and the sample nucleic acid extraction reagent used to contain lysate, isopropanol and 1×TE buffer as examples:

[0048] (1) Take out the cervical cotton swab sample, vortex and mix well, pipette 1mL sample into a 1.5mL centrifuge tube, centrifuge at 12000rpm for 1min, carefully discard the supernatant, and keep the precipitate;

[0049] (2) Add 500 μl of lysate to the precipitate in (1), shake and mix well, and put it in a water bath or dry bath at 100°C for 10 minutes, wherein the lysate contains 0.2M NaCl, 10mM NaOH, 0.1% SDS, 0.5% NP-40 and 0.5% Tween 1×TE buffer at -20;

[0050] (3) Add 500 μl of isopropanol, vortex and mix, place at room temperature for 2 minutes, centrifuge at 12000 rpm for 5 minutes, discard the supernatant, and place at room temperature for 2 minutes;

[0051] (4) Add 50 μl of 1×TE buffer solution, fully dissolve, let...

Embodiment 2

[0052] Embodiment 2: fluorescent PCR reaction steps

[0053] (1) Prepare high-risk HPV fluorescent PCR reaction solution: 4μl 10×PCRBuffer (100mM Tris-HCl, 500mM KCl); 0.08μldATP (0.4mM), 0.08μldTTP (0.4mM), 0.08μldCTP (0.4mM), 0.08μldGTP (0.4mM) ; 0.8 μl BSA (10 mg / mL); 6.4 μl MgCl 2 (25mM);0.05μlHPV16F(100μM)、0.08μlHPV16F(100μM)、0.08μlProbe1(100μM);0.05μlHPV18F(100μM)、0.08μlHPV18F(100μM)、0.08μlProbe2(100μM);0.08μlHPV31F(100μM)、0.08μlHPV35F(100μM ), 0.08 μl HPV31 / 35R (100 μM), 0.08 μl HPV33F (100 μM), 0.08 μl HPV52F (100 μM), 0.08 μl HPV58F (100 μM), 0.08 μl HPV33 / 52 / 58R (100 μM), 0.06 μl Probe3 (100 μM), 0.06 μl F55 μ M (100 μM), HPV4008 μ M); 0.06μlHPV45R(100μM)、0.08μlHPV59F(100μM)、0.06μlHPV59R(100μM)、0.06μlProbe4(100μM);0.08μlHPV39 / 68F(100μM)、0.08μlHPV39 / 68R(100μM)、0.06μlProbe5(100μM);0.08μlHPV53F(100μM )、0.08μlHPV53R(100μM)、0.08μlHPV56 / 66F(100μM)、0.08μlHPV56R(100μM)、0.08μlHPV66R(100μM)、0.06μlProbe6(100μM);0.08μlHPV26F(100μM)、0.06μlHPV51 / 82F(100μM)、0.08μlHPV26 / 51 / 82R (...

Embodiment 3

[0061] Embodiment 3: clinical sample detection

[0062] According to the method in Example 1, the DNA in 140 cases of HPV cervical swab samples was extracted, and then the DNA in the 140 cases of HPV cervical swab samples was subjected to fluorescent PCR amplification according to the method in Example 2. At the same time, for the convenience of comparison, the Roche Combas 48014 high-risk HPV (ie HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68 and 66) detection kits were used to detect the 140 The DNA in the HPV cervical swab sample was detected, and the detection results are shown in Table 4.

[0063] Table 4 Test results

[0064]

[0065]

[0066] The results in Table 4 show that among these 140 clinical samples, the present invention is consistent with the detection results of 134 clinical samples in the Roche kit, but there are also 6 clinical samples, and the present invention can detect the high-risk type The presence of HPV, while the Roche kit cannot det...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method, oligonucleotide and kit for detecting common high-risk HPV (human papilloma viruses). A fluorescence PCR (polymerase chain reaction) technology is adopted, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 26, 53, 66, 73 and 82 which possibly exist in a sample are subjected to initial detection and type identification. By the method, oligonucleotide and kit for detecting the common high-risk HPV, 18 high-risk types can be detected simultaneously, and the HPV 16 and 18 can be subjected to genetic typing simultaneously. On the basis of 18 types of high-risk HPV and affinity of other types on a phylogenetic tree, a high-risk HPV primer and a probe are designed, a background fluorescence value is reduced remarkably while detection accuracy, sensitivity and specificity are guaranteed, detection flux is increased remarkably, and detection cost is greatly reduced.

Description

technical field [0001] The invention belongs to the field of biological science and biotechnology, in particular to a method for detecting 18 common high-risk HPVs, oligonucleotides and kits, using fluorescent PCR technology to detect HPV16, 18, 31 that may exist in clinical samples , 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 26, 53, 66, 73 and 82 for preliminary detection and type identification. Background technique [0002] Human papillomavirus (HPV) is a small DNA virus that can infect human epidermis and mucosal squamous epithelium, and can cause diseases such as genital warts and cervical cancer. Humans are the only host of HPV. The HPV genome is a double-stranded circular DNA, about 7900 base pairs (bp) long, containing 8 open reading frames (ORFs), consisting of 3 gene regions, including the early region (E region), the late region (L region) and non-coding regions or upstream regulatory regions. The E region can be divided into seven genes in sequence: E6, E7, E1, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/70C12Q1/68C12N15/11C12R1/93
CPCC12Q1/708
Inventor 刘学锋张太松吕娜朱丽敏
Owner ACON BIOTECH (HANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products